American Portfolios Advisors’s Agilon Health AGL Stock Holding History

American Portfolios Advisors’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$14.7K	Buy	+25	New	+$15K	﹤0.01%	2344

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

American Portfolios Advisors's AGL Position: Q3 2022 in Review

American Portfolios Advisors opened a new position in Agilon Health (AGL) in Q3 2022: 25 shares worth $14.7K. The stake represents ﹤0.01% of the portfolio and ranks #2344 among its holdings.

176 funds tracked by Wall St. Rank hold AGL as of Q3 2022.

American Portfolios Advisors held 25 shares of Agilon Health worth $14.7K as of Q3 2022.
Agilon Health was a new American Portfolios Advisors position in Q3 2022.
Agilon Health made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2344 holding.
176 funds tracked by Wall St. Rank held Agilon Health as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.